AliRaza Cancer Research UK Cambridge Institute, UniversityUnited Kingdom

Dr Ali is Leader of the Systems Cancer Pathology group, based at CRUK Cambridge Institute, University of Cambridge, Associate Director for Clinical Academic Training , and an Honorary Consultant Pathologist at Addenbrookes hospital. He read medicine in Cardiff and began his training as a pathologist there before moving to Cambridge to undertake a PhD in the quantitative pathology and genomics of breast cancer, under the supervision of Prof Carlos Caldas. He completed his specialist clinical training in Cambridge as an NIHR Clinical Lecturer before moving to University of Zurich. In Zurich, he worked under the supervision of Prof Bernd Bodenmiller, inventor of imaging mass cytometry. There, he conducted research using highly multiplexed epitope-based tissue imaging to understand the principles of spatial organisation that characterise breast tumour ecosystems. His group uses imaging mass cytometry to understand the spatial dynamics of breast cancer through disease progression and treatment, in order to identify adaptations and biomarkers associated with relapse and response.